Market Highlights

---

Get the latest Indian stock / share market highlights, BSE/NSE stock news, business research reports & details - updated daily by Money Times.

---

May 21, 2025

• Daily Morning Report                                 
• Date: 21.05.2025
• NIFTY OUTLOOK: 24,683.90      FII: -10,016.10 cr      DII: 6,738.39 cr
• As discussed yesterday, market behaviour remained on expected lines. Nifty faced selling pressure near the resistance zone of 25,030, and during the afternoon session, it breached the support levels of 24,863–24,833. This led to intensified profit booking down to 24,670, with a final close at 24,683.90.
• A long bearish candle on the daily chart now suggests a short-term correction in the market. If the downward move continues and Nifty decisively breaks below 24,601, it may further slip to 24,518–24,436. If selling pressure intensifies, it could even test 24,353.
• On the upside, immediate resistance is seen at 24,767–24,833/849. A breakout above these levels and sustained strength may push the index toward 24,933–25,015.
• Bank Nifty OUTLOOK
• SPOT: 54,877.35     PCR: 0.74     Max CE OI: 63,000  Max PE OI: 55,000
• On 20th May 2025, Bank Nifty closed at 54,877.35, down 0.98% from the previous close. The index made a high of 55,568.35 and a low of 54,829.45 during the session.
• Technical View on Daily Chart
• Key levels to watch are 55,645 as resistance and 54,750 as support. A breakout above 55,645 could take the index to 55,935, while a breach below 54,750 may lead to a decline toward 54,280.
• The Relative Strength Index (RSI) stands at 56.30. (Below 30 is considered oversold, and above 70 is overbought.)
• Bank Nifty Day SMA Analysis:
• Bank Nifty is trading above 6 out of 8 key SMAs (10, 30, 50, 100, 150, 200-day) and below 2 SMAs (5 and 20-day).
• No candlestick pattern was identified in Bank Nifty.
• Macros .
• 1. Dollar index @ 99.57
• 2. Vix @ 18.09
• 3. Crude @ 66.40
• 4. 10 years Bond yield @ 4.507
• Note:
• Investors remained cautious over the U.S. economy after Moody’s downgraded its credit rating last week, while trade talks with Washington continued to be in focus.
• Several Federal Reserve officials warned that trade tariffs could fuel inflation and result in interest rates staying higher for longer.
• Sentiment was further dented by reports suggesting that Israel may be planning an attack on Iran’s nuclear facilities, raising concerns over escalating geopolitical tensions in the Middle East.
• As far as Indian equities are concerned, markets are likely to react negatively tomorrow due to heavy FII selling — Rs. 10,000 cr. in the cash segment, Rs. 2,784 cr. in index futures, and Rs. 4,032 cr. in stock futures — totalling Rs. 16,800 cr. worth of equity sell-off.
• We need to closely monitor the 24,500 level on the lower side. A breakdown below this could lead to further selling pressure.
• Contributed by
• Ashok bhandari : INH000019549
• -------------------------------------xxxxxxx-------------------------------------------------------------------xxxxxxx---------------------------------
• BEAT THE STREET BULLETIN
• Date: 21-May-2025
• Telegram: \[t.me/beatthestreet10]
• ---
• Q4 RESULTS
• UNITED SPIRITS: Net profit up 25% YoY at ₹10.52 Cr, revenue up 11% YoY; margins at 17.16%.
• ASTER DM: Posts ₹79 Cr profit vs ₹24 Cr loss YoY; EBITDA up 21%, margins at 19.23%.
• SUYOG TELEMATICS: Swings to ₹13.17 Cr loss vs ₹15.68 Cr profit YoY; margins plunge to 13.75%.
• EMAMI PAPER: Net profit down 86% YoY at ₹3.92 Cr; EBITDA drops 56%, margins at 6.5%.
• PICCADILLY AGRO: Net profit down 10% YoY; EBITDA down 2%, margins at 25.65%.
• 63 MOONS TECH: Turns to ₹12.12 Cr profit vs ₹26.3 Cr loss QOQ; revenue up 41% YoY.
• LAXMI ORGANIC: Net profit down 51% YoY at ₹21.7 Cr; margins drop to 8.3%.
• NHPC: Net profit jumps 57% YoY to ₹853 Cr; revenue up 24%, margins at 46.44%.
• ONMOBILE: Posts ₹7.9 Cr loss vs ₹0.5 Cr loss YoY; margins drop to 0.5%.
• ---
• NEW PROJECTS / EXPANSIONS
• KAMAT HOTELS: Signs new “IRA by Orchid” hotel in Dwarka, Gujarat; opening in Oct 2025.
• WAAREE RENEWABLE: Launches new solar energy arm “Sunsational Power”.
• ASSOCIATED ALCOHOLS: Launches premium whisky ‘Hillfort’ in Maharashtra.
• PCBL: Subsidiary Aquapharm starts polymer production at Mahad, adding 9.2 KTA capacity.
• LEMON TREE: Opens 5th hotel in Goa at Arpora; Phase 1 now operational.
• ---
• POWER PURCHASE AGREEMENTS / RENEWABLE INITIATIVES
• AHASOLAR: Signs 25-year PPA with UGVCL for 2.5 MW solar plant under DREBP scheme.
• ADVAIT ENERGY: Forms green hydrogen unit ‘Advaiteco Technologies’.
• ---
• ACQUISITION / JV
• GMM PFAUDLER: Completes 51% JV acquisition in Poland to set up new facility.
• ---
• COLLABORATION / MoU
• VLE E-GOVERNANCE: Signs ₹800 Cr MoU for Sankalp Smart City EPC contract.
• THEMIS MEDICARE: Signs MoU with Gedeon Richter for RTML management fee.
• ---
• LEADERSHIP / STRUCTURAL CHANGES
• NURECA: Approves merger of Nureca Tech; strikes off non-functional unit.
• ---
• USFDA APPROVAL
• VEERHEALTH CARE: Gets USFDA clearance; targets ₹100 Cr revenue via US exports.
• ---
• CLARIFICATION
• PROTEAN EGOV: Clarifies PAN 2.0 exit has minimal impact on ongoing services.
• ---
• BULK DEALS / FII STAKE CHANGE
• EDELWEISS: Carnelian Asset buys 80 lakh shares at ₹90.40 in bulk deal.
• ---
• SALE / BUYOUT
• CAPITAL INDIA FINANCE: Gets RBI nod to sell home loan unit for ₹267 Cr to Weaver Services.
• @beatthestreet10
• Citi on Torrent Pharma
• Maintain Buy with target price of Rs 4,000
• Q4: Healthy underlying trends in the branded markets
• Margins surprise positively
• Believe margin expansion trend will continue on the back of operating leverage in the branded segments
• @beatthestreet10
• Jefferies on Torrent Pharma
• Maintain Buy; Cut target price to Rs 3740 from Rs 3970
• Q4: Remains a steady ship
• India business to continue its outperformance
• Brazil growth to improve; US challenges to persist in near term
• @beatthestreet10
• Macquarie On BEL
• Maintain Outperform; Hike target price to Rs 400 from Rs 365
• Q4 beat; enhanced base order visibility
• Solid end to FY25 with Q4 EBITDA/PAT comfortably beating consensus on higher-than-expected EBITDA margins
• FY26E margin guide surprised positively
• @beatthestreet10
• JPMorgan On Hindalco
• Maintain Overweight; Hike target price to Rs 720 from Rs 680
• Better-than-expected product mix in Aluminum downstream and lagged impact of higher alumina prices aided Q4
• EBITDA expansion to continue over the next 2-3 years as downstream projects ramp up and captive coal mining commences
• @beatthestreet10
• JEFFERIES ON DIXON TECH
• Maintains 'Underperform' Rating & Hikes Target Price To ₹13,300 From ₹12,660
• Q4 Profit Was A Beat As Mobile+EMS Dominated Product Mix
• Competition Is A Concern, Post Mobile PLI Expiry In FY27
• Likely Co Would Already Be Catering To High Share Of Domestic Outsourcing By FY27
• Raise EPS & Estimate FY25-28 PAT CAGR At Over 33%
• Stock Trades At 97x FY26 P/E; Valuation Rich
• @beatthestreet10
• JEFFERIES ON DIXON TECH
• Maintains 'Underperform' Rating & Hikes Target Price To ₹13,300 From ₹12,660
• Q4 Profit Was A Beat As Mobile+EMS Dominated Product Mix
• Competition Is A Concern, Post Mobile PLI Expiry In FY27
• Likely Co Would Already Be Catering To High Share Of Domestic Outsourcing By FY27
• Raise EPS & Estimate FY25-28 PAT CAGR At Over 33%
• Stock Trades At 97x FY26 P/E; Valuation Rich
• @beatthestreet10
• GOVT SOURCES ON INDIA-EU FTA
• India's Chief negotiator Satya Srinivas likely to go to Brussels today to fastrack negotiations for EU FTA - CNBCTV 18
• India, EU pursuing two-stage approach to finalise FTA, discussing early harvest pact similar to the one with Australia
• India, EU also discussing bilateral investment protection agreement and recognition of geographical indications (Gls)
• Alert: 11th round of India-EU FTA talks were held in New Delhi from 12th to 16th May
• EU has sought amendments in India's Patents Act to allow 'evergreening' of patents in pharmaceuticals
• Alert: India had refused to accept demands from UK, Switzerland for data exclusivity to protect generic pharma industry
• @beatthestreet10
• TRUMP : Announces $175 bn Golden Dome Missile Shield project for US - ET NOW
• Says dome will be done in about 3 years
• Dome should be fully operational by end of my term
• This is important for success and survival of US
• @beatthestreet10
• INOX GREEN: CO SIGNS AGREEMENTS FOR O&M OF 639 MWP OF SOLAR PROJECTS
• @beatthestreet10
• CLSA on BEL
• O-P, TP Raised to Rs 423
• Key message from 4Q was that slowdown in its inflows & backlog in FY25, on a high base, is over.
• BEL is set for a lofty $6bn (84% of backlog) in order wins in next 15 months & its record margins set stage for 8-11% EPS increases over FY26-27
• @beatthestreet10
• MS on BEL
• OW, TP Raised to Rs 418
• BEL remains a preferred pick for its execution track record, better control of supply chain (vs. HAL). & strong orders in pipeline.
• BEL targets revenue CAGR of 15-17.5% over the next five years and 20% thereafter
• @beatthestreet10
• PROTEAN EGOV TECHNO : LARGE TRADE NSE
• MASSACHUSETTS INSTITUTE OF TECHNOLOGY SOLD 4.01 LKH SHARES (0.99 % STAKES) @ ₹ 1026 /SHARE
• HRTI PRIVATE LIMITED BOUGHT 0.61 LKH SHARES ( 0.15 % STAKES ) @ ₹ 1033.92 /SHARE
• @beatthestreet10
• HEALTHY LIFE AGRITEC : LARGE TRADE BSE
• NIGHTINGALE GROWTH BOUGHT 2.34 LKH SHARES ( 0.94 % STAKE ) @ ₹ 60.99/SHARE
• @beatthestreet10
• AXISCADES : LARGE TRADE BSE
• SUDHAKAR GANDE SOLD 1.10 LKH SHARES ( 0.25 % STAKES) @ ₹ 979.85 /SHARE
• HINDUSTHAN INFRASTRUCTURE BOUGHT 1.10 LKH SHARES ( 0.25 % STAKES ) @ ₹ 979.85/SHARE
• @beatthestreet10
• Nomura on Zydus
• Buy, TP Rs 1140
• 4QFY25: Lower gRevlimid contribution led to EBITDA miss; FY26F guidance ahead of our estimates
• Co expects US revenue to grow in high single-digit in FY26F vs current estimate of a 2% decline
• Co expects EBITDA margin to be more than 26% in FY26F
• @beatthestreet10
• CITI on Zydus
• Sell, TP Rs 900
• Reported strong 4Q
• As per management, gRevlimid was minimal in 4Q & started seeing price correction that means QoQ jump in US sales either driven by gMyrbetriq or channel filling in Sitagliptin; otherwise, gross margins wouldn’t have moved much QoQ
• However, FY26E EBITDA margin guidance of 26%+ (c300-400bps lower than FY25), along with management’s comment on the US baseline sales close to US$1bn, suggests that baseline EBITDA margins are in the range of 20-22%.
• @beatthestreet10
• *News Headlines from Business News Agencies:*
• *Business Standard*
• JLR aims to double India biz in 3-4 years, expand products, network
• Hindalco to acquire coal block owner EMMRL for long-term fuel security
• Suzuki Motorcycle India to set up ₹1,200 cr manufacturing plant in Haryana
• Honda slows EV push globally, eyes India manufacturing unit by 2028
• BLS E-Services to expand Business Correspondent network to 60,000 agents
• India needs 5% agri growth yearly to become developed by 2047: Chouhan
• CCI must give swift approval to M&As that don't harm competition: FM
• New India Assurance to launch parametric insurance for climate risks: CMD
• Embassy Office Parks REIT raises Rs 2K cr via debt issuance at 7.21%
• CloudSEK raises $19 million for AI-led innovation, global expansion
• South Indian cities dominate GCC office leasing in Q1 CY25: Report
• Nazara Tech completes acquisition of UK-based Curve Games for ₹247 cr
• *Economic Times*
• India's infrastructure output grows 0.5% in April against 4.6% in March
• Maruti Suzuki partners Standard Chartered Bank for dealer financing solutions
• TVS Motor unveils electric three-wheeler TVS King EV MAX at Rs 2.95 lakh
• IHH Healthcare increases damages claim against Daiichi Sankyo to Rs 11,800 cr over Fortis acquisition dispute
• Govt procures over 290 lakh tons of wheat so far, may hit 320-325 lakh tons: Pralhad Joshi
• NSEL says receives overwhelming response on one-time settlement scheme
• K P Energy gets transmission link for its 100MW wind project
• FSSAI asks States to curb use of illegal ripening agents, synthetic coatings on fruits
• KPI Green Energy gets transmission connectivity for subsi's 642.6 MW wind project
• Max Healthcare Q4 Results: Revenue rises 29%, PAT at Rs 376 crore
• Foxconn to expand India focus with $1.5 billion investment
• *Mint*
• India eyes cheap oil to refill strategic reserves amid geopolitical turmoil
• US tariffs continue to weigh on India, other emerging markets: Moody’s
• High court denies L&T relief in case against MMRDA over ₹16,000-cr road projects
• Hindalco Industries Q4 Results: Cons PAT jumps 66% YoY to ₹5,283 crore
• India to introduce global tendering for public procurement post UK FTA
• Piccadily Becomes The 1st Indian Alcobev Company to Adapt NFC Technology
• Page Industries needs sustained growth to support rich valuations
• Zomato's foreign ownership cap may lead to MSCI exit, says Jefferies
• Airtel, Google team up to counter Jio’s free cloud blitz
• Indian equities expected to outshine other asset classes in FY26
• NHPC, NTPC, EIL yet to alter arbitration clause despite Centre's nudge
• @beatthestreet10
• Aegis Logistics
• Proposed Initial Public Offering ('IPO') Of Aegis Vopak Terminals Limited - Filing Of The Red Herring Prospectus (RHP)
• AVTL files ₹2800 Cr IPO; may cease as Aegis Logistics subsidiary post-IPO
• @beatthestreet10
• PCBL Chemical
• Aquapharm starts commercial polymer production, adding 9.2 KTA capacity, total 21.8 KTA annually
• @beatthestreet10
• Themis Medicare
• MoU with Gedeon Richter for management fee of USD 440,000 or 3% of RTML revenue, subject to targets.
• @beatthestreet10
• VL E-Governance signs ₹800 Cr EPC MoU for Sankalp Industrial Smart City project
• @beatthestreet10
• Biocon Biologics' ustekinumab biosimilar launched in Japan via Yoshindo after PMDA approval.
• @beatthestreet10
• Quicktouch Tech
• QuickPay gets RBI in-principle Payment Aggregator License, advancing fintech operations.
• @beatthestreet10
• Laxmi Organic and Hitachi Energy to produce eco-efficient gas; production starts next financial year.
• @beatthestreet10
• Kamat Hotels
• Signing Of Agreement For Management And Operation Of 'IRA By Orchid Hotel At Dwarka, Gujarat"
• signs management deal for 49-room IRA by Orchid hotel in Dwarka, opening Oct 2025.
• @beatthestreet10